Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-24 @ 12:20 PM
Study NCT ID:
NCT04711161
Status:
SUSPENDED
Last Update Posted:
2024-01-23
First Post:
2020-12-24
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Sponsor:
Green3Bio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-24
First Submit QC Date:
None
Study First Post Date:
2021-01-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-19
Last Update Post Date:
2024-01-23
Last Update Post Date Type:
ACTUAL